Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects

NCT04893512 is registered in ClinicalTrials.gov with Syneos Health as lead sponsor.

NCT NCT04893512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04893512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects
Lead sponsor
Syneos Health
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2021
Completion date
November 11, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 (covid-19)